These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 26052006

  • 1. Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease.
    Börgeson E, Johnson AM, Lee YS, Till A, Syed GH, Ali-Shah ST, Guiry PJ, Dalli J, Colas RA, Serhan CN, Sharma K, Godson C.
    Cell Metab; 2015 Jul 07; 22(1):125-37. PubMed ID: 26052006
    [Abstract] [Full Text] [Related]

  • 2. Lipoxin A4 attenuates adipose inflammation.
    Börgeson E, McGillicuddy FC, Harford KA, Corrigan N, Higgins DF, Maderna P, Roche HM, Godson C.
    FASEB J; 2012 Oct 07; 26(10):4287-94. PubMed ID: 22700871
    [Abstract] [Full Text] [Related]

  • 3. Lipoxin A4 may attenuate the progression of obesity-related glomerulopathy by inhibiting NF-κB and ERK/p38 MAPK-dependent inflammation.
    Guo YP, Jiang HK, Jiang H, Tian HY, Li L.
    Life Sci; 2018 Apr 01; 198():112-118. PubMed ID: 29499280
    [Abstract] [Full Text] [Related]

  • 4. Lipoxins Regulate the Early Growth Response-1 Network and Reverse Diabetic Kidney Disease.
    Brennan EP, Mohan M, McClelland A, Tikellis C, Ziemann M, Kaspi A, Gray SP, Pickering R, Tan SM, Ali-Shah ST, Guiry PJ, El-Osta A, Jandeleit-Dahm K, Cooper ME, Godson C, Kantharidis P.
    J Am Soc Nephrol; 2018 May 01; 29(5):1437-1448. PubMed ID: 29490938
    [Abstract] [Full Text] [Related]

  • 5. AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin.
    Börgeson E, Wallenius V, Syed GH, Darshi M, Lantero Rodriguez J, Biörserud C, Ragnmark Ek M, Björklund P, Quiding-Järbrink M, Fändriks L, Godson C, Sharma K.
    Diabetologia; 2017 Apr 01; 60(4):729-739. PubMed ID: 28188334
    [Abstract] [Full Text] [Related]

  • 6. Lipoxins Protect Against Inflammation in Diabetes-Associated Atherosclerosis.
    Brennan EP, Mohan M, McClelland A, de Gaetano M, Tikellis C, Marai M, Crean D, Dai A, Beuscart O, Derouiche S, Gray SP, Pickering R, Tan SM, Godson-Treacy M, Sheehan S, Dowdall JF, Barry M, Belton O, Ali-Shah ST, Guiry PJ, Jandeleit-Dahm K, Cooper ME, Godson C, Kantharidis P.
    Diabetes; 2018 Dec 01; 67(12):2657-2667. PubMed ID: 30213823
    [Abstract] [Full Text] [Related]

  • 7. Exercise training inhibits inflammation in adipose tissue via both suppression of macrophage infiltration and acceleration of phenotypic switching from M1 to M2 macrophages in high-fat-diet-induced obese mice.
    Kawanishi N, Yano H, Yokogawa Y, Suzuki K.
    Exerc Immunol Rev; 2010 Dec 01; 16():105-18. PubMed ID: 20839495
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of M1 macrophage activation in adipose tissue by berberine improves insulin resistance.
    Ye L, Liang S, Guo C, Yu X, Zhao J, Zhang H, Shang W.
    Life Sci; 2016 Dec 01; 166():82-91. PubMed ID: 27702567
    [Abstract] [Full Text] [Related]

  • 9. Lipoxin A₄ and benzo-lipoxin A₄ attenuate experimental renal fibrosis.
    Börgeson E, Docherty NG, Murphy M, Rodgers K, Ryan A, O'Sullivan TP, Guiry PJ, Goldschmeding R, Higgins DF, Godson C.
    FASEB J; 2011 Sep 01; 25(9):2967-79. PubMed ID: 21628447
    [Abstract] [Full Text] [Related]

  • 10. Lipoxins and aspirin-triggered 15-epi-lipoxins are the first lipid mediators of endogenous anti-inflammation and resolution.
    Serhan CN.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Sep 01; 73(3-4):141-62. PubMed ID: 16005201
    [Abstract] [Full Text] [Related]

  • 11. Lipoxin A4 attenuation of endothelial inflammation response mimicking pancreatitis-induced lung injury.
    Lv W, Lv C, Yu S, Yang Y, Kong H, Xie J, Sun H, Andersson R, Xu D, Chen B, Zhou M.
    Exp Biol Med (Maywood); 2013 Dec 01; 238(12):1388-95. PubMed ID: 24000382
    [Abstract] [Full Text] [Related]

  • 12. Second-generation beta-oxidation resistant 3-oxa-lipoxin A4 analogs.
    Guilford WJ, Parkinson JF.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Dec 01; 73(3-4):245-50. PubMed ID: 15985364
    [Abstract] [Full Text] [Related]

  • 13. The effect of Lipoxin A4 on the interaction between macrophage and osteoblast: possible role in the treatment of aseptic loosening.
    Li G, Wu P, Xu Y, Yu Y, Sun L, Zhu L, Ye D.
    BMC Musculoskelet Disord; 2009 Jun 02; 10():57. PubMed ID: 19490628
    [Abstract] [Full Text] [Related]

  • 14. High-fat diet induced obesity primes inflammation in adipose tissue prior to liver in C57BL/6j mice.
    van der Heijden RA, Sheedfar F, Morrison MC, Hommelberg PP, Kor D, Kloosterhuis NJ, Gruben N, Youssef SA, de Bruin A, Hofker MH, Kleemann R, Koonen DP, Heeringa P.
    Aging (Albany NY); 2015 Apr 02; 7(4):256-68. PubMed ID: 25979814
    [Abstract] [Full Text] [Related]

  • 15. Lipoxin A(4) reduces lipopolysaccharide-induced inflammation in macrophages and intestinal epithelial cells through inhibition of nuclear factor-kappaB activation.
    Kure I, Nishiumi S, Nishitani Y, Tanoue T, Ishida T, Mizuno M, Fujita T, Kutsumi H, Arita M, Azuma T, Yoshida M.
    J Pharmacol Exp Ther; 2010 Feb 02; 332(2):541-8. PubMed ID: 19846590
    [Abstract] [Full Text] [Related]

  • 16. Chrysin attenuates inflammation by regulating M1/M2 status via activating PPARγ.
    Feng X, Qin H, Shi Q, Zhang Y, Zhou F, Wu H, Ding S, Niu Z, Lu Y, Shen P.
    Biochem Pharmacol; 2014 Jun 15; 89(4):503-14. PubMed ID: 24704474
    [Abstract] [Full Text] [Related]

  • 17. Roles of lipoxin A4 in preventing paracetamol-induced acute hepatic injury in a rabbit model.
    Xia J, Zhou XL, Zhao Y, Zhu YQ, Jiang S, Ni SZ.
    Inflammation; 2013 Dec 15; 36(6):1431-9. PubMed ID: 23851615
    [Abstract] [Full Text] [Related]

  • 18. CTLA-4Ig immunotherapy of obesity-induced insulin resistance by manipulation of macrophage polarization in adipose tissues.
    Fujii M, Inoguchi T, Batchuluun B, Sugiyama N, Kobayashi K, Sonoda N, Takayanagi R.
    Biochem Biophys Res Commun; 2013 Aug 16; 438(1):103-9. PubMed ID: 23872146
    [Abstract] [Full Text] [Related]

  • 19. Impaired resolution of inflammation in human chronic heart failure.
    Reina-Couto M, Carvalho J, Valente MJ, Vale L, Afonso J, Carvalho F, Bettencourt P, Sousa T, Albino-Teixeira A.
    Eur J Clin Invest; 2014 Jun 16; 44(6):527-38. PubMed ID: 24673112
    [Abstract] [Full Text] [Related]

  • 20. ALOX5AP Overexpression in Adipose Tissue Leads to LXA4 Production and Protection Against Diet-Induced Obesity and Insulin Resistance.
    Elias I, Ferré T, Vilà L, Muñoz S, Casellas A, Garcia M, Molas M, Agudo J, Roca C, Ruberte J, Bosch F, Franckhauser S.
    Diabetes; 2016 Aug 16; 65(8):2139-50. PubMed ID: 27207555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.